Literature DB >> 26242689

Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis.

Shoichi Sasaki1.   

Abstract

The blood-spinal cord barrier (BSCB) of the spinal cord capillary consists of non-fenestrated endothelial cells with tight junctions, basal laminae, pericytes and astrocyte feet processes, referred to as a "neurovascular unit." The primary function of the BSCB is the maintenance and control of homeostasis of the spinal cord parenchyma by the selective transport of molecules and cells from the systemic compartment. Dysfunction of the BSCB shows important function in the etiology or progression of several pathological conditions of the spinal cord, including amyotrophic lateral sclerosis (ALS). However, the role of BSCB in the pathogenesis of ALS is still unclear. Here the changes of BSCB in sporadic ALS patients were studied by electron microscopy to determine whether the BSCB is disrupted and involved in the pathogenesis of motor neuron degeneration. A total of 358 and 366 cross-sectioned capillaries were quantitatively examined in controls and ALS patients, respectively. The frequency of degenerated endothelia and pericytes, vacuolar changes of the cytoplasm in the endothelia and pericytes, and the replication of basement membranes was significantly higher in ALS patients than in the controls (P = 0.0175). The areas of the capillaries with diameters of ≤ 5 µm in the ALS patients were significantly smaller than those in the controls (P = 0.0124). The frequency of collagen fiber content of more than a moderate degree around the perivascular space was significantly higher in the ALS patients compared to the controls (P = 0.048), although there was no significant difference in the mild degree of accumulation of collagen fibers. Thus, the BSCB may be disrupted in sporadic ALS patients due to increased permeability and reduced microcirculation, leading to motor neuron degeneration and to the progression of the disease.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  amyotrophic lateral sclerosis; blood-spinal cord barrier; collagen fiber; endothelial cell; neurovascular unit; pericyte; tight junction

Mesh:

Year:  2015        PMID: 26242689     DOI: 10.1111/neup.12221

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  18 in total

Review 1.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

2.  Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.

Authors:  Jin-Yue Li; Zheng-Yi Cai; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  Neurol Sci       Date:  2021-11-26       Impact factor: 3.830

Review 3.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

4.  Detection of endothelial cell-associated human DNA reveals transplanted human bone marrow stem cell engraftment into CNS capillaries of ALS mice.

Authors:  Svitlana Garbuzova-Davis; Kayla J Boccio; Jared Ehrhart; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Brain Res Bull       Date:  2021-02-02       Impact factor: 4.077

5.  Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis.

Authors:  Hirotoshi Magota; Masanori Sasaki; Yuko Kataoka-Sasaki; Shinichi Oka; Ryo Ukai; Ryo Kiyose; Rie Onodera; Jeffery D Kocsis; Osamu Honmou
Journal:  Mol Brain       Date:  2021-05-07       Impact factor: 4.041

6.  Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice.

Authors:  Jiaying Dai; Weihao Lin; Minying Zheng; Qiang Liu; Baixuan He; Chuanming Luo; Xilin Lu; Zhong Pei; Huanxing Su; Xiaoli Yao
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

Review 7.  Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis.

Authors:  Giovanni Nardo; Maria Chiara Trolese; Caterina Bendotti
Journal:  Front Neurol       Date:  2016-06-13       Impact factor: 4.003

Review 8.  VEGF Signaling in Neurological Disorders.

Authors:  Joon W Shim; Joseph R Madsen
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

Review 9.  Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis.

Authors:  Svitlana Garbuzova-Davis; Jared Ehrhart; Paul R Sanberg; Cesario V Borlongan
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

Review 10.  Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis.

Authors:  Svitlana Garbuzova-Davis; Robert Shell; Hilmi Mustafa; Surafuale Hailu; Alison E Willing; Paul R Sanberg; Cesario V Borlongan
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.